Effect of Transcranial Direct Current Stimulation on Functional Capacity in Schizophrenia: A Study Protocol for a Randomized Controlled Trial

Abstract

Schizophrenia patients elicit a wide range of psychopathology, including psychotic symptoms, mood symptoms, and cognitive impairment. Functional capacity is defined as the ability to perform everyday living skills, which is linked to cognition and real-world functional outcome. In a previous open trial, we demonstrated that transcranial direct current stimulation (tDCS), one of the neuromodulation methods, improved cognition and functional capacity in 28 patients with schizophrenia. However, since it was a pilot study, a controlled trial is needed. Therefore, we present a study protocol for a randomized controlled trial designed to evaluate the effect of tDCS on functional capacity in patients with schizophrenia. This is a two-arm, parallel-design, randomized controlled trial, in which patients and assessors will be blinded. Patients meeting DSM-5 criteria for schizophrenia will be enrolled and randomized to receive either active or sham stimulation (with 10 sessions in five consecutive days). Functional capacity will be evaluated by the UCSD Performance-based Skills Assessment-Brief as primary outcome. Cognition, as measured by the Brief Assessment of Cognition in Schizophrenia, and psychotic symptoms, as measured by the Positive and Negative Syndrome Scale, will also be evaluated. Data will be collected at baseline, immediately after the last stimulation, and 1 and 2 months thereafter. If active stimulation elicits greater effects compared with those of sham stimulation, it may add to the efforts to improve functional outcomes by neuromodulation in patients with schizophrenia.Trial registrationUMIN000028224; .

Effect of transcranial direct current stimulation on postpartum depression: A study protocol for a randomized controlled trial

“…The outcomes of a previous meta-analysis on the duration and length of tDCS sessions offer us an opportunity to further optimize this intervention (Labree et al, 2022 ). Relevant studies (Narita et al, 2017 ) also demonstrate the efficacy of the designed controlled trial for evaluating the effect of tDCS on the treatment of PPD.…”

Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis

“…The distribution of cognitive performance at baseline would obviously be expected to influence the results of the RCTs. In fact, some RCTs with schizophrenia patients have used inclusion criteria for the cognitive function scores e.g., by setting a cutoff point ( Narita et al, 2017 ). Further RCTs are thus needed to examine if augmentation with 5-HT 1A partial agonists is beneficial for improving multiple neurocognitive functions in patients with substantial cognitive decline.…”

Facilitative Effects of Transcranial Direct Current Stimulation on Semantic Memory Examined by Text-Mining Analysis in Patients With Schizophrenia

“…Several limitations should be mentioned. First, the current study used the data obtained in a previous one-armed open label study ( 25 , 33 ) that did not adopt sham comparisons. Second, sample size was considerably larger in healthy controls compared to patients.…”

“…tDCS was administered according to a method previously reported ( 33 ) in line with a previous study of tDCS on cognition in patients with Schizophrenia ( 34 ). Participants underwent 10 active tDCS sessions in 5 consecutive days, twice per day.…”